CPA
NARI

Capital Performance Advisors’s Inari Medical, Inc. Common Stock NARI Stock Holding History

Capital Performance Advisors’s Portfolio NARI Stock Details NARI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-10
Closed -$412 – 2857
2024
Q3 		$412 Buy
+10
New +$480 ﹤0.01% 2333

Other funds holding NARI

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
HM
HCC Manager Chicago, Illinois $10.3M AUM 6.8% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Mackenzie Financial
Mackenzie Financial Toronto Ontario, Ontario, Canada $83.3B AUM 31.19% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $33.1B AUM 11.16% 1-Year Est. Return

Capital Performance Advisors's NARI Position: Q4 2024 in Review

Capital Performance Advisors sold out of Inari Medical, Inc. Common Stock (NARI) in Q4 2024, closing a stake of 10 shares — an estimated $412 sold.

Capital Performance Advisors first reported a position in NARI in Q3 2024 and held it in 1 quarter. The position peaked at $412 in Q3 2024. 258 funds tracked by Wall St. Rank hold NARI as of Q4 2024.

  • Capital Performance Advisors reported no remaining Inari Medical, Inc. Common Stock position as of Q4 2024 after selling out during the quarter.
  • Capital Performance Advisors sold 10 Inari Medical, Inc. Common Stock shares in Q4 2024, an estimated $412.
  • Capital Performance Advisors first reported a position in Inari Medical, Inc. Common Stock in Q3 2024 and held it in 1 quarter.
  • Capital Performance Advisors's Inari Medical, Inc. Common Stock position peaked at $412 in Q3 2024.
  • 258 funds tracked by Wall St. Rank held Inari Medical, Inc. Common Stock as of Q4 2024.

Based on Capital Performance Advisors's 13F filing for Q4 2024, filed 31 Jan 2025.